IR DEPARTMENT
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
XPN Technologies Group Ltd (XPN) lists on the ASX following well supported A$12.5m IPO 2021-12-16 07:17
AUSTRALIAN LIFE SCIENCE COMPANY, QBIOTICS, LAUNCHES STELFONTA® ITS LEAD VETERINARY PHARMACEUTICAL IN AUSTRALIA, FOLLOWING LAUNCHES IN OTHER KEY GLOBAL MARKETS 2021-12-16 03:58
EZZ bolsters Board with industry veteran Glenn Cross as new Chair 2021-12-02 05:00
EZZ accelerates genomic health focus with launch of two new biotic products 2021-11-23 04:00
Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech 2021-11-22 09:24
New EZZ genomic products attract strong Chinese interest at CIIE 2021 2021-11-11 04:00
Kazia Enrols First Patient to EVT801 Phase I Clinical Trial 2021-11-04 08:38
EZZ Marks Transition to Genomic Health Following Exceptional FY21 Performance 2021-10-29 04:05
Island Pharmaceuticals to discuss its potential dengue fever preventative at Pharma Meeting Brazil & Latam 2021 2021-10-20 18:00
Kazia Therapeutics to Present at LD Micro Main Event 2021-10-06 22:00
Zantrene® kills melanoma cancer cells that overproduce FTO 2021-09-30 11:58
EZZ Delivers Strong FY21 Operational Performance, Declares Dividend 2021-09-30 11:39
EZZ moves closer to breakthrough with world-first study into anti-aging product, NMN 2021-09-24 05:00
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria 2021-09-16 08:45
HaemaLogiX raises $10 million to advance multiple myeloma treatments 2021-09-09 05:00
ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics 2021-08-24 19:26
Openpay Group Ltd Quarterly Update and Appendix 4C 2021-07-28 21:42
Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day 2021-07-21 22:00
Qbiotics concludes successful $85 million capital raise 2021-06-28 09:36
First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma 2021-06-03 06:00
1 2 3